Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery

Deepti Swain; Asitkumar Sethi; Prasantkumar Bal; Kamalakanta Swain; Sidharth Sraban Routray

doi:10.5455/njppp.2023.13.07331202207072022

2023, Vol: 13, Issue: 3

13/3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2023; 13(2): 340-343

doi: 10.5455/njppp.2023.13.07331202207072022

Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery

Deepti Swain, Asitkumar Sethi, Prasantkumar Bal, Kamalakanta Swain, Sidharth Sraban Routray.

Abstract
Background: Paravertebral block can be given for pain management after modified radical mastectomy (MRM). Although many additives to ropivacaine in PVB have been tried for post-operative analgesia, none has been found ideal.

Aims and Objectives: We have compared the duration of analgesia in PVB using adjuvant like dexmedetomidine with ropivacaine after MRM.

Materials and Methods: Sixty female patients posted for MRM and axillary dissection were split into two groups. Group R administered ultrasound-guided PVB with 20 ml ropivacaine 0.5% and Group RD administered 20 ml of 0.5% ropivacaine with dexmedetomidine 1 mcg/kg. After confirming PVB, surgery was done under general anesthesia in all patients. Time for 1st analgesia requirement was the main objective of our trial. Other objectives were to record visual analog scale scores and total analgesic need.

Results: Post-operative analgesia duration was increased in the group RD (7.11 ± 1.42 h) in contrary to Group R (3.68 ± 1.85 h). Total paracetamol consumption post-operative 24 h was decreased in Group RD (1.63 ±0.89 g) in contrary to Group R (2.74 ± 0.76 g).

Conclusion: Dexmedetomidine in PVB provides prolonged pain relief after MRM.

Key words: Dexmedetomidine; Ropivacaine; PVB; Analgesia

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Deepti Swain Articles by Asitkumar Sethi Articles by Prasantkumar Bal Articles by Kamalakanta Swain Articles by Sidharth Sraban Routray
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Swain D, Sethi A, Bal P, Swain K, Routray SS. Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 340-343. doi:10.5455/njppp.2023.13.07331202207072022

Web Style

Swain D, Sethi A, Bal P, Swain K, Routray SS. Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery. https://www.njppp.com/?mno=76189 [Access: March 01, 2023]. doi:10.5455/njppp.2023.13.07331202207072022

AMA (American Medical Association) Style

Swain D, Sethi A, Bal P, Swain K, Routray SS. Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 340-343. doi:10.5455/njppp.2023.13.07331202207072022

Vancouver/ICMJE Style

Swain D, Sethi A, Bal P, Swain K, Routray SS. Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery. Natl J Physiol Pharm Pharmacol. (2023), [cited March 01, 2023]; 13(2): 340-343. doi:10.5455/njppp.2023.13.07331202207072022

Harvard Style

Swain, D., Sethi, . A., Bal, . P., Swain, . K. & Routray, . S. S. (2023) Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery. Natl J Physiol Pharm Pharmacol, 13 (2), 340-343. doi:10.5455/njppp.2023.13.07331202207072022

Turabian Style

Swain, Deepti, Asitkumar Sethi, Prasantkumar Bal, Kamalakanta Swain, and Sidharth Sraban Routray. 2023. Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 340-343. doi:10.5455/njppp.2023.13.07331202207072022

Chicago Style

Swain, Deepti, Asitkumar Sethi, Prasantkumar Bal, Kamalakanta Swain, and Sidharth Sraban Routray. "Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 340-343. doi:10.5455/njppp.2023.13.07331202207072022

MLA (The Modern Language Association) Style

Swain, Deepti, Asitkumar Sethi, Prasantkumar Bal, Kamalakanta Swain, and Sidharth Sraban Routray. "Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery." National Journal of Physiology, Pharmacy and Pharmacology 13.2 (2023), 340-343. Print. doi:10.5455/njppp.2023.13.07331202207072022

APA (American Psychological Association) Style

Swain, D., Sethi, . A., Bal, . P., Swain, . K. & Routray, . S. S. (2023) Efficacy of dexmedetomidine as adjuvant to ropivacaine in paravertebral block for post-operative analgesia in breast cancer surgery. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 340-343. doi:10.5455/njppp.2023.13.07331202207072022

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information



Copyright © 2023 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article